Hims & Hers Health, Inc. (NYSE: HIMS) is a telehealth and consumer health platform that completed a business combination with Oaktree Acquisition Corp., a blank-check company sponsored by Oaktree Capital Group that priced its initial public offering in 2019. The November 2019 Form 10-Q on file with the SEC reflects the SPAC's early operational period prior to announcing and closing its merger target. The transaction was completed in January 2021, at which point the combined entity began trading on the New York Stock Exchange under the HIMS ticker. The company now operates across multiple telehealth verticals, including sexual health, dermatology, hair loss treatment, and mental wellness. For complete filing history, deal timelines, and analytics on HIMS and hundreds of other de-SPAC companies, sign up for full data access on SpacDesk.